The RhythmStar platform fits seamlessly into clinical practice and its interoperability support easily integrates with electronic medical record (EMR) systems. Unlike these systems, RhythmStar instantly transfers data wirelessly to enable faster ECG analysis with rapid report turnaround, so that care providers receive diagnostic reporting weeks faster than with mail back data retrieval methods.
RHYTHMSTAR HEART MONITOR MANUAL
"We've monitored over 1 million patients and look forward to accelerating adoption of our innovative remote cardiac monitoring solution to reach even more patients." Alternative monitoring systems require patients to send the wearable device back to the manufacturer for manual data retrieval, analysis and report generation. RhythMedix is committed to transforming and simplifying the diagnostic pathway to enable faster diagnosis, without missing a beat," stated Brian Pike, President, of RhythMedix.
"We are especially pleased to launch expanded capabilities so close to National AFib Awareness Month. The addition of long-term continuous electrocardiogram (ECG) monitoring up to 14 days provides clinicians with a complete and flexible cardiac monitoring solution, with rapid report turnaround in less than 48 hours, to address a diverse range of patient needs. 18, 2022 /PRNewswire/ - RhythMedix, a leader in remote cardiac monitoring and proprietary arrhythmia detection algorithms, today announced expanded modalities for its RhythmStar® System (RhythmStar). Strategic addition of Extended Wear Holter monitoring modality enhances portfolio offering and positions company for accelerated growth RhythmStar integrates seamlessly into clinical practice, helping physicians make informed treatment decisions that allow patients to enjoy life, without missing a beat.RhythMedix® Expands Monitoring Capabilities of Its RhythmStar® System, the First Wearable Cardiac Monitor with Built-I. The sleek, one-piece device, with built-in 4G cellular technology, is the first wearable multi-modality cardiac monitor (Holter, Event and MCT) that connects patients and clinicians for improved patient care. "It also allows me to remain connected to my patients throughout their monitoring period, which may expedite a life-saving diagnosis." "The novel wearable RhythmStar monitoring device offers increased patient compliance and allows for accurate assessment of cardiac rhythm in real time," states Steven DaTorre, M.D., a Clinical Cardiologist at Cooper University Health Care in New Jersey. 1,2 While remote cardiac monitoring has improved arrhythmia detection, patient compliance and timely access to heart activity currently limit accurate and timely diagnosis. Heart arrhythmias are a major health concern that doubles the risk of death in an estimated 33.5 million people worldwide. RhythmStar is now available with HeartTime™ on-demand telemetry mode, an innovative platform that allows physicians to evaluate cardiac activity and expedite care via a telemedicine appointment, limiting the need for an in-person office visit. The technology enables rapid ECG analysis and reporting of cardiac abnormalities by RhythMedix's team of US-based certified technicians, who alert physicians if an arrhythmia of concern is detected. The novel cardiac telemetry monitor is discreetly worn for extended remote monitoring without the need for an additional phone or communication device.
18, 2021 /PRNewswire/ - RhythMedix, a leader in remote cardiac monitoring, today announced the release of its next-generation RhythmStar ® wearable device with built-in 4G cellular connectivity.
0 kommentar(er)
